Results 111 to 120 of about 41,454 (219)

New Ebola Outbreak in Africa Is a Major Test for the WHO [PDF]

, 2018
On May 8, the Democratic Republic of Congo (DRC) notified the World Health Organization (WHO) of a confirmed outbreak of Ebola in Bikoro, on the shores of Lake Tumba in Équateur Province. Ebola in the DRC is not unexpected.
Gostin, Lawrence O.
core   +1 more source

Prescription for the People: An Activist\u27s Guide to Making Medicine Affordable for All [PDF]

, 2017
[Excerpt] Because every cure starts with an accurate diagnosis, in this book I explain how and why the current medicines system is dysfunctional and corrupt.
Quigley, Fran
core   +1 more source

Neglected Dimensions of Global Security: The Global Health Risk Framework Commission [PDF]

, 2016
The world has experienced global health crises ranging from novel influenzas (H5N1 and H1N1) and coronaviruses (SARS and MERS) to the Ebola and Zika viruses.
Gostin, Lawrence O., Kelley, Patrick W., Mundaca-Shah, Carmen C.   +2 more
core   +1 more source

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

Биопрепараты: Профилактика, диагностика, лечение
INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these ...
T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg   +14 more
doaj   +1 more source

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

npj Vaccines
Ebola virus disease (EVD) is a filoviral infection caused by virus species of the Ebolavirus genus including Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV).
Myra Happe, Amelia R. Hofstetter, Jing Wang, Galina V. Yamshchikov, LaSonji A. Holman, Laura Novik, Larisa Strom, Francis Kiweewa, Salim Wakabi, Monica Millard, Colleen F. Kelley, Sarah Kabbani, Srilatha Edupuganti, Allison Beck, Florence Kaltovich, Tamar Murray, Susanna Tsukerman, Derick Carr, Carl Ashman, Daphne A. Stanley, Aurélie Ploquin, Robert T. Bailer, Richard Schwartz, Fatim Cham, Allan Tindikahwa, Zonghui Hu, Ingelise J. Gordon, Nadine Rouphael, Katherine V. Houser, Emily E. Coates, Barney S. Graham, Richard A. Koup, John R. Mascola, Nancy J. Sullivan, Merlin L. Robb, Julie A. Ake, Kirsten E. Lyke, Mark J. Mulligan, Julie E. Ledgerwood, Hannah Kibuuka, the VRC 208 and RV 422 study team   +40 more
doaj   +1 more source

[Ebola, the first vaccines available].

Medecine sciences : M/S, 2020
In the recent years, Ebola virus has been responsible for several major epidemics. Research efforts have allowed the development and evaluation in the field of several vaccine candidates. At present, two of them are already approved and used in the fight against the virus in the Democratic Republic of Congo.
Martin, Baptiste, Volchkov, Viktor, Reynard, Olivier   +2 more
openaire   +2 more sources

Fostering collaboration on post-Ebola clinical research in Liberia

The Lancet Global Health, 2016
Moses B F Massaquoi, Stephen B Kennedy, Jemee K Tegli, Fatorma K Bolay, Francis N Kateh   +4 more
doaj   +1 more source

The Hemorrhagic Fever: Ebola and Other Viruses

Pakistan Journal of Medicine and Dentistry
Presently, Ebola epidemic in West Africa emphasizes an immediate need to update management guidelines of viral hemorrhagic fever and develop new vaccines and treatments.
Faraz Ahmed Baig, Amna Hamid
doaj  

The Global Risks Report 2016, 11th Edition [PDF]

, 2016
Now in its 11th edition, The Global Risks Report 2016 draws attention to ways that global risks could evolve and interact in the next decade. The year 2016 marks a forceful departure from past findings, as the risks about which the Report has been ...

core  

Comparison of the Efficacy of Different Schemes for Using Recombinant Vector Vaccines against Ebola Fever, Based on Vaccinia Virus, MVA Strain

Проблемы особо опасных инфекций
The aim of this review was to investigate the use of the vaccines based on vaccinia virus, MVA stain, and adenovirus vectors for the prevention of Ebola virus disease.
L. F. Stovba, O. V. Chukhralya, D. I. Pavel’ev, N. K. Chernikova, S. V. Borisevich   +4 more
doaj   +1 more source